Significance of the number of brain metastases for identifying patients who don't need whole brain radiotherapy: implication as oligometastases of the brain
- PMID: 29296350
- PMCID: PMC5658883
Significance of the number of brain metastases for identifying patients who don't need whole brain radiotherapy: implication as oligometastases of the brain
Abstract
Background and purpose: To investigate the significance of the number of brain metastases in the treatment with stereotactic radiotherapy (SRT) with or without whole brain radiotherapy (WBRT).
Material and methods: Between February 2003 and October 2010, 218 consecutive patients with brain metastases who underwent SRT alone or WBRT plus SRT were investigated. The prognostic factors affecting overall survival and brain progression-free survival were analyzed by multivariate and univariate analysis. By logistic regression analysis, factors associated with the number recurrences of brain metastasis after SRT were also investigated.
Results: The median overall and brain progression-free survivals were 7.2 months and 4.3 months, respectively. Significant prognostic factors for overall survival in multivariate analyses were performance status (hazard ratio [HR] = 1.71, 95% confidence interval [CI] 1.13-2.57, p = 0.01) and the number of brain metastases (HR = 1.75, 95% CI 1.08-2.83, p = 0.02). Cut-off line of the number of brain metastases was between 3 and 4, and 3 or fewer brain metastases were significantly better than 4 or more in prognosis by univariate and multivariate analysis (p < 0.01, p = 0.02).
Conclusions: The patients with 3 or fewer brain metastases were associated with brain progression free survival and 3 or fewer brain relapse. Repeated SRT without WBRT may be effective for patients with 3 or fewer brain metastases.
Keywords: brain metastases; oligometastases; stereotactic radiosurgery; stereotactic radiotherapy; whole brain radiotherapy.
Figures
References
-
- Nomura K: Frequency and characterisitc feature of metastatic brain tumors in Japan. Jpn J Neurosurg 2003; 12:323.
-
- Ruderman NB, Hall TC: Use of Glucocorticoids in the Palliative Treatment of Metastatic Brain Tumors. Cancer 1965; 18: 298-306. - PubMed
-
- Borgelt B, Gelber R, Kramer S, et al. : The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1980; 6: 1-9. - PubMed
-
- Molenaar R, Wiggenraad R, Verbeek-de Kanter A, et al. : Relationship between volume, dose and local control in stereotactic radiosurgery of brain metastasis. J Br Neurosurg 2009; 23: 170-178. - PubMed
-
- Tokuuye K, Akine Y, Sumi M, et al. : Fractionated stereotactic radiotherapy of small intracranial malignancies. Int J Radiat Oncol Biol Phys 1998; 42: 989-94. - PubMed
LinkOut - more resources
Full Text Sources